No Data
No Data
Microelectrophysiology (688351): The first quarter met expectations and is expected to accelerate quarterly
The 1Q24 results are in line with our expectations of the company's 1Q24 results: revenue of 89 million yuan, +71% year-on-year; net profit to mother of 4.17 million yuan (loss of 9.33 million yuan in 1Q23). Revenue and profit are in line with our expectations
Microelectronic Physiology (688351.SH): Net profit of 4.169 million yuan in the first quarter
On April 25, Ge Longhui (688351.SH) released its first quarter report. Operating revenue was 89.15 million yuan, up 71.01% year on year, net profit of 4.169 million yuan, after deducting non-net loss of 1.35 million yuan, and basic earnings per share of 0.0089 yuan.
Microelectrophysiology (688351): 24Q1 performance exceeded expectations and the number of 3D surgeries increased rapidly
Core view: The company's performance in the first quarter of '24 exceeded expectations. According to Wind and the company's quarterly report in '24, the company achieved total operating revenue of 89 million yuan (YOY +71.01%); net profit to mother of 204 million yuan
Microelectrophysiology (688351): A bright start to 1Q24 lays the tone for high annual growth
The performance of 1Q24 is impressive. I am optimistic that the company achieved revenue of 89,153 million yuan (yoy +71.0%) and net profit of 4.169 million yuan (net loss to mother of 9.326 million yuan in 1Q23).
Microelectrophysiology (688351) Review Report: Accelerated Product Collection, Increased Product Approval, and Continued Entry into the Atrial Fibrillation Market
Incident: On the evening of April 25, 2024, the company released its report for the first quarter of 2024: revenue of 89 million yuan, an increase of 71.01% over the previous year. The main reason is that the company actively explores domestic and foreign markets, and its products are widely marketed
Dongfang Wealth Securities released a research report on April 24 stating that it gave Microelectronic Physiology (688351.SH) a purchase rating, and the target price was 29.58 yuan. The main reasons for the rating include: 1) leading domestic electrophysi
Dongfang Wealth Securities released a research report on April 24 stating that it gave Microelectronic Physiology (688351.SH) a purchase rating, and the target price was 29.58 yuan. The main reasons for the rating include: 1) leading domestic electrophysiological strength, and the collaborative layout of the three energy sources of ice and fire power breaks through cutting-edge barriers to foreign investment; 2) the industry's key technologies have broken through bottlenecks, and surgical treatment positions have risen, broadening the incremental space in the blue ocean market; 3) in the era of rapid growth in surgical volume, domestic technology follow-up, collection accelerates the key localization process; 4) The company's major new products frequently highlight R&D strength, and the pulsed electric field melts and completes the final puzzle. (Mainichi Keizai Shimbun)
No Data